Icon

KLONOPIN (nda017533)- (0.125MG,0.25MG,0.5MG,1MG,2MG)

CLONAZEPAM CHEPLAPHARM
0.125MG,0.25MG,0.5MG,1MG,2MG
No No
Expired Expired
None None
None No
Klonopin is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. Klonopin is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-V.
6 0 5
Total Other Developers 5
Drugs with Suitability No
0.125MG ** ** - - -
0.25MG ** ** - - -
0.5MG ** ** Up - 4
1MG ** ** Down - 4
2MG ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** **** ***** ********** *.*.* *********** ********* ***/**, *******, *****, *** **, ***** ******** (***) ***
****** **** **** ************** ********** ***. *********** ** *** ******* ******, ********** ****, **** ****, *******, ****** (***) ***
****** ******* ********* ******* ********* *** *********** *** ****** ***, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***
****** ******** *** ******** ***** ** *** */*/* ******** ************ *********** **** ******** ****., *********, ***** ******** (**) *****, ****** ****** (***) ***
****** ******* ******* ******** ******* ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.